Aptamers are single stranded DNA or RNA molecules which are extremely versatile and binds targets with high specificity and selectivity as it has a tendency to form helices and single-stranded loops. Aptamer can be used against various molecule target such as toxins, peptides, proteins, viruses and whole cell. Aptamers are designed for therapeutic use in the body due to it stability and high bioavailability. Furthermore, aptamers are nucleotide analogues of antibodies and aptamer generation is significantly cheaper and easier as compared to that of production of antibodies.
Factors driving demand for global aptamers market includes continuous development for high-quality aptamers by research institutes and manufacturers. Furthermore, increasing number of applications of aptamers is expected to drive the global aptamers market over the forecast period. However, stringent regulations and lack of awareness regarding the use of aptamers is expected to limit the market growth over the forecast period.
Types segment includes nucleic acid aptamers, and peptide aptamers. The nucleic acid aptamers segment contributes major market share owing to increasing number research and development activities and product approval.
End user segment includes biotechnology and pharmaceutical industry, contract research organization, and academic and research institutions. The biotechnology and pharmaceutical industry segment is expected to witness rapid growth over the forecast period owing to the wide application of aptamers in treatment of disease.
Do Inquiry of the Report Here: https://marketresearch.biz/report/aptamers-market/#inquiry
Regional segmentation includes North America, Europe, Latin America, Asia Pacific and Middle East and Africa. Europe is expected to witness highest growth as compared to other regions, this is attributed to increasing number of manufacturer of aptamers in the region. North America contributes major market in global aptamers market and maintains its dominance over the forecast period.
Some prominent players in the global aptamers market are AM Biotechnologies, LLC, Aptagen LLC, Aptamer Sciences, Inc., Aptus Biotech S.L., Base Pair Biotechnologies, Inc., NeoVentures Biotechnology, Inc., SomaLogic Inc., TriLink BioTechnologies, Inc., Vivonics, Inc., and Noxxon Pharma.